Results 91 to 100 of about 38,863 (158)

Inflammatory Pericardial Effusion With Hemorrhagic Conversion in Takotsubo Cardiomyopathy

JACC: Case Reports
Background: Takotsubo cardiomyopathy (TC) is a reversible stress-induced cardiomyopathy that may be triggered by acute neurologic events. Significant pericardial effusions associated with TC are uncommon, and hemorrhagic transformation is rarely reported.
Ameer Odeh, MD, Nausheen Akhter, MD, Gokce Deniz Ardor, MD, Mohammed Ruzieh, MD, MSE   +3 more
doaj   +1 more source

Koroner Arter Hastalığında Doğru Antiplatelet Seçimi [PDF]

Koroner arter hastalığı yaygın bir kardiyovasküler hastalıktır. Antiplatelet tedavi, koroner arter hastalığının tüm formlarında, özellikle de perkütan koroner girişim uygulanan hastalarda tedavinin temel taşıdır.
Yurtdaş, Mustafa, Özdemir, Mahmut
core   +1 more source

Bilateral Ultrasound Guided Supraclavicular Block in a Patient on Antiplatelet Drugs

, 2015
A 63 year old male hypertensive and diabetic patient, with coronary artery and chronic obstructive pulmonary disease, presented with bilateral both bone forearm fracture.
Lokesh Kumar KS, Rajalakshmi J
core  

Antiplatelet Therapy in Acute Coronary Syndrome

, 2017
Antiplatelet agents have for decades been used to improve outcomes in patients with acute coronary syndromes and have become increasingly valued, not only for their antithrombotic properties but also for their anti-inflammatory effects.
Albert Ferro, null null, Kerry Layne
core   +1 more source

Recurrent Stent Thrombosis Following Myocardial Infarction Associated With VITT-Like Antibodies

JACC: Case Reports
Early stent thrombosis is a rare complication of percutaneous intervention and is associated with significant 30-day mortality. We present a novel case of multiple recurrent early stent thrombosis consistent with spontaneous vaccine-induced thrombotic ...
Zulqarnain Khan, MD, Imari Patel, MD, Tiffany Gardner, PharmD, Xin Wei, MD, Michael Cheng, MD, Mark R. Vesely, MD, Roberto M. Benitez, MD, Ann B. Zimrin, MD, Libin Wang, MD, Aloke V. Finn, MD   +9 more
doaj   +1 more source

Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics

, 2015
Amber L Beitelshees,1,* Deepak Voora,2,* Joshua P Lewis,1,* 1Program for Personalized and Genomic Medicine and Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA; 2Center for Applied Genomics
Beitelshees AL, Lewis JP, Voora D
core  

Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention

, 2010
Role of antiplatelet therapy in secondary stroke prevention is of major significance. Antiplatelet agents predominantly in use are aspirin, clopidogrel, and combination regimes.
Srivastava Padma
core  

Review: Antiplatelet drugs: what comes next?

, 2011
Antiplatelet drugs are important components in the management of atherothrombotic vascular disease. However, several limitations restrict the safety and efficacy of current antiplatelet therapy in clinical practice.
Elisaf, M. S., Mikhailidis, D. P., Liberopoulos, E. N., Kei, A. A., Florentin, M.   +4 more
core  

Antiplatelet drugs in cardiological practice: Established strategies and new developments

, 2008
Florian Krötz, Hae-Young Sohn, Volker KlaussCardiology, Medical Policlinic, Ludwig-Maximilians-Universität, Ziemssenstr. 1, 80336 MünchenAbstract: A common pathophysiological course in vascular diseases is an overwhelming activation and ...
Florian Krötz, Volker Klauss, Hae-Young Sohn   +2 more
core  

Novel agents in antiplatelet therapy

, 2010
Antiplatelet therapy is the cornerstone of management of acute coronary syndromes. Currently used antiplatelet drugs present several limitations that provoke new searches.

core